Cannabinoids: a class of unique natural products with unique pharmacology
- 11 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Rendiconti Lincei. Scienze Fisiche e Naturali
- Vol. 32 (1), 5-15
- https://doi.org/10.1007/s12210-020-00966-y
Abstract
No abstract availableKeywords
Funding Information
- Consiglio Nazionale delle Ricerche
- Canadian Institutes of Health Research
This publication has 94 references indexed in Scilit:
- “Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain ControlACS Chemical Neuroscience, 2012
- The major central endocannabinoid directly acts at GABA A receptorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling PathwaysChemical Reviews, 2011
- Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesiaNature Chemical Biology, 2011
- Pharmacological characterization of GPR55, a putative cannabinoid receptorPharmacology & Therapeutics, 2010
- Phytocannabinoids beyond the Cannabis plant – do they exist?British Journal of Pharmacology, 2010
- The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathwaysBMC Biochemistry, 2009
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and CannabidiolJournal of Biological Chemistry, 2008
- Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind studyBMJ, 2008
- Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppressionProceedings of the National Academy of Sciences of the United States of America, 2006